These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 8614008)

  • 1. Serum sex hormone levels after menopause and subsequent breast cancer.
    Berrino F; Muti P; Micheli A; Bolelli G; Krogh V; Sciajno R; Pisani P; Panico S; Secreto G
    J Natl Cancer Inst; 1996 Mar; 88(5):291-6. PubMed ID: 8614008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
    Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
    J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
    Key T; Appleby P; Barnes I; Reeves G;
    J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.
    Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A; Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):169-76. PubMed ID: 19124495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
    Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
    Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
    Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
    Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
    James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
    Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
    Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.
    Zhang X; Tworoger SS; Eliassen AH; Hankinson SE
    Breast Cancer Res Treat; 2013 Feb; 137(3):883-92. PubMed ID: 23283524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.